<DOC>
	<DOCNO>NCT02011906</DOCNO>
	<brief_summary>The aim study determine effect omega 3 supplementation concurrent supplementation vitamin E serum level antioxidant enzymes expression PGC-1a , h TERT , FOXO1 , FOXO3a , SIRT1 , SIRT3 , SIRT6 gene PBMC cell patient coronary artery disease</brief_summary>
	<brief_title>The Effects Omega 3 Vitamin E Supplementation Serum Antioxidant Enzymes Gene Expressions PGC-1a , h TERT , FOXOs SIRTs CAD Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>literate , willingness participation , CAD patient 45 65 year old , body mass index &lt; 30 , avoidance dietary supplement , vitamin herbal product least 3 month throughout intervention , willing maintain body weight study people use vitamin E omega 3 supplement last 3 month , chronic renal disease , cancer , Hepatobilliary diseases , hematological disorder , hypo hyperthyroidism , diabetes , treatment PPARgamma agonists Thiazolidinediones , Smokers</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>antioxidant enzyme</keyword>
	<keyword>omega 3</keyword>
	<keyword>vitamin E</keyword>
	<keyword>CAD</keyword>
	<keyword>Sirtuins</keyword>
	<keyword>FOXOs</keyword>
</DOC>